Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-354-4 | CAS number: 330-54-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 Oct 2006 to 07 Dec 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP- Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.2 (Acute Toxicity (Inhalation))
- GLP compliance:
- yes
- Test type:
- fixed concentration procedure
Test material
- Reference substance name:
- Diuron
- EC Number:
- 206-354-4
- EC Name:
- Diuron
- Cas Number:
- 330-54-1
- Molecular formula:
- C9H10Cl2N2O
- IUPAC Name:
- 3-(3,4-dichlorophenyl)-1,1-dimethylurea
- Details on test material:
- - Name of test material (as cited in study report): Diuron Technical
- Substance type: Off white powder
- Physical state: Powder
- Analytical purity: > 98%
- Lot/batch No.: 0321205
- Storage condition of test material: Room temperature, in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley Crl:CD (SD) IGS BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, Margate, Kent, UK.
- Age at study initiation: Approximately eight to twelve weeks old.
- Weight at study initiation: 200g to 350g
- Fasting period before study: No
- Housing: The animals were housed in groups of five by sex in solid-floor polypropylene cages with stainless steel lids, furnished with softwood flakes (Datesand Lts., Cheshire, UK) and provided with environmental enrichment items; wooden chew blocks (B & K Universal Ltd, Hull, UK) and cardboard ‘’fun tunnels’’ (Datesand Lts., Cheshire, Uk).
- Diet: Free access to food (EU Rodent Diet 5LF2, BCM IPS Linited, London, UK) was allowed throughout the study, except during the exposure period.
- Water: Free access to mains drinking water was allowed throughout the study, except during the exposure period.
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): The rate of air exchange was at least fifteen changes per hour.
- Photoperiod : The lighting was controlled to give twelve hours continuous light and twelve hours darkness.
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: A cylindrical exposure chamber, SAG 410 solid aerosol generator and a metered compressed air supply.
- Exposure chamber volume: The cylindrical exposure chamber had a volume of approximately 30 litres (dimensions: 28 cm diameter x 50 cm high).
- Method of holding animals in test chamber: Each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber and sealed by means of a rubber ‘O’ ring. Only the nose of each animal was exposed to the test atmosphere.
- Source and rate of air: Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality before it was introduced to the SAG 410.
- System of generating particulates/aerosols: A dust atmosphere was produced from the test material using a SAG 410 Solid Aerosol Generator (TOPAS GmbH, Dresden, Germany). The SAG 410 was connected to a metered compressed air supply.
- Method of particle size determination:
The particle size of the generated atmosphere inside the exposure chamber was determined three times during the exposure period using a Marple Personal Cascade Impactor (Westech IS Ltd, Beds., UK). This device consisted of six impactor stages (9.0, 6.5, 3.7, 1.6, 1.0 and 0.33 µm cut points) with stainless steel collection substrates and a back up glass fibre filter, housed in an aluminium sampler. The sampler was temporarily sealed in a sampling port in the animals’ breathing zone and a suitable; known of exposure air was drawn through it using a vacuum pump. The collection substrates and backup filter were weighed before and after sampling and the weight of test material, collected at each stage, calculated by difference. The mean amount for each stage was used to determine the cumulative amount below each cut-off point size. In this way, the proportion (%) of aerosol less than 9.0, 6.5, 3.7, 1.6, 1.0 and 0.33 µm was calculated. The mean values were converted to probits and plotted against Log10 cut-point size. From this plot, the Mass Median Aerodynamic (MMAD) was determined (as the 50% point) and the geometric standard deviation was calculated. In addition the proportion (%) of aerosol less than 4 µm (considered to be the inhalable fraction) was determined (See table 5)
- Treatment of exhaust air: The extract from the exposure chamber passed through a 'scrubber' trap and was connected with a high efficiency filter to a metered exhaust system.
- Temperature, humidity, pressure in air chamber: The temperature and relative humidity inside the exposure chamber were measured by an electronic thermometer/humidity meter (Hanna Instruments Ltd, Beds., UK) located in a vacent port in the animals' breathing zone of the chamber and was recorded every thirty minutes throughout the four- hour exposure period.
TEST ATMOSPHERE
- Brief description of analytical method used:
The actual chamber concentration was measured at regular intervals during the exposure period. The gravimetric method used glass fibre filter placed in a filter holder. The holder was temporarily sealed in a vacant port in the exposure chamber in the animals’ breathing zone and a suitable known volume of exposure chamber air was drawn through the filter using a vacuum pump. Each filter was weighed before and after sampling in order to calculate the weight of collected test material. The difference in the two weights, divided by the volume of atmosphere sampled, gave the actual chamber concentration (See table 4).
- Samples taken from breathing zone: yes
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution: 56.6% was less than 4µm (See table 5).
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 3.59 µm/ 2.56 - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5.05 mg/L - Mean achieved concentration
14.5 mg/L -Nominal - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were observed for clinical signs at hourly intervals during exposure, immediately on removal from the restraining tubes at the end of exposure, one hour after termination of exposure and subsequently once daily for fourteen days. Any deaths or evidence of overt toxicity were recorded at each observation. Individual bodyweights were recorded prior to treatment on the day of exposure and on Day 7 and 14 or at death.
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.05 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: Mean achieved Atmosphere Concentration.
- Mortality:
- Only one death occurred in a group of ten rats exposed to a mean achieved atmosphere concentration of 5.05 mg/L for four hours (See table 1).
- Clinical signs:
- other: Common abnormalities noted during the study included increased respiratory rate, hunched posture, pilo-erection and wet fur. All male animals appeared normal by day 6 post-exposure, whereas all surviving female animals appeared normal by day 11.
- Body weight:
- Male animals showed good bodyweight increases during both weeks of the recovery period, surviving female animals exhibited a reduced bodyweight gain or slight bodyweight loss during week 1. During week 2 three female animals showed good development whereas another animals remained at the same weight (See table 2)
- Gross pathology:
- Apart from one instance of abnormally dark lungs no macroscopic abnormalities were detected amongst surviving animals at necropsy. The following macroscopic abnormalities were detected in the animal that died during the course of the study at necropsy:
Lungs- abnormally dark;
Liver- accentuated lobular pattern (See table 3).
Any other information on results incl. tables
Table 1: Mortality Data
Mean Achieved Atmosphere Concentration (mg/L) |
Sex |
Deaths During Exposure |
Deaths Post Exposure (1 hour) |
Deaths During Day of Observation |
Total Deaths |
|||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8-14 |
|||||
5.05 |
M |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1/10 |
F |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Table 2: Individual Bodyweights
Mean Achieved Atmosphere Concentration (mg/L) |
Animal Number and Sex |
Bodyweight (g) on Day: |
Increment (g) During Week: |
||||
0 |
7 |
14 |
At Death |
1 |
2 |
||
5.05 |
1 Male |
309 |
338 |
377 |
|
29 |
39 |
2 Male |
328 |
381 |
434 |
|
53 |
53 |
|
3 Male |
330 |
379 |
428 |
|
49 |
49 |
|
4 Male |
300 |
335 |
379 |
|
35 |
44 |
|
5 Male |
312 |
347 |
386 |
|
35 |
39 |
|
6 Female |
233 |
- |
- |
215 |
- |
- |
|
7 Female |
219 |
212 |
212 |
|
-7 |
0 |
|
8 Female |
244 |
251 |
278 |
|
7 |
27 |
|
9 Female |
224 |
222 |
232 |
|
-2 |
10 |
|
10 Female |
236 |
240 |
253 |
|
4 |
13 |
- Animal dead
Table 3: Individual Necropsy Findings
Mean Achieved Atmosphere Concentration (mg/L) |
Macroscopic Observations |
Animal Number and Sex |
|||||||||
1 Male |
2 Male |
3 Male |
4 Male |
5 Male |
6* Female |
7 Female |
8 Female |
9 Female |
10 Female |
||
5.05 |
Lungs: Abnormally Dark |
|
|
P |
|
|
P |
|
|
|
|
Liver: Accentuated Lobular Pattern |
|
|
|
|
|
P |
|
|
|
|
|
|
N |
N |
|
N |
N |
|
N |
N |
N |
N |
P = Finding present
N =No abnormalities detected
*= Animal died during study
Table 4: Exposure Chamber Atmosphere Concentrations:
Duration of exposure (minutes) |
Net Weight of sampling (mg) |
Volume of Air Sampled (mg) |
Chamber Flow Rate (L/min) |
Atmosphere Concentration (mg/L) |
1 |
12.29 |
2 |
55 |
6.15 |
7 |
10.30 |
2 |
55 |
5.15 |
17 |
11.71 |
2 |
55 |
5.86 |
24 |
11.22 |
2 |
55 |
5.56 |
38 |
11.43 |
2 |
55 |
5.72 |
46 |
8.93 |
2 |
55 |
4.47 |
55 |
5.14 |
2 |
55 |
2.57 |
63 |
9.14 |
2 |
55 |
4.57 |
77 |
12.25 |
2 |
55 |
6.13 |
85 |
11.29 |
2 |
55 |
5.65 |
101 |
9.70 |
2 |
55 |
4.85 |
116 |
10.56 |
2 |
55 |
5.28 |
135 |
10.30 |
2 |
55 |
5.15 |
150 |
10.09 |
2 |
55 |
3.82 |
168 |
7.63 |
2 |
55 |
4.29 |
176 |
8.57 |
2 |
55 |
4.29 |
194 |
9.50 |
2 |
55 |
4.75 |
206 |
11.45 |
2 |
55 |
5.73 |
223 |
9.41 |
2 |
55 |
4.71 |
234 |
10.80 |
2 |
55 |
5.40 |
Mean achieved atmosphere concentration (mg/L) = 5.05
Standard deviation = 0.85
Applicant's summary and conclusion
- Executive summary:
In a reliable acute inhalation toxicity study performed according to OECD 403, five male and female Sprague-Dawley rats were noseonly exposed to 5.05 mg/L Diuron, the max. achievable atmosphere concentration (Griffith, 2007). One female rat died on day 1 post-exposure.Clinical signs noted during the study included increased respiratory rate, hunched posture, pilo-erection and wet fur. At necropsy, no macroscopic abnormalities were detected amonst surviving animals except for one instance of abnormally dark lungs. The animal that died showed abnormally dark lungs and an accentuated lobular pattern in the liver. Based on the results of this , the LC50 in the rat is considered to be > 5.05 mg/L Diuron.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
